T T Biss
- An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhageT Biss
Newcastle Haemophilia Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK
Haemophilia 9:638-41. 2003..There have been only two previous reports of acquired haemophilia A in association with myelodysplastic disorders and no previous report of an association with a myeloproliferative disorder...
- Myelofibrosis and angiodysplasia of the colon: another manifestation of portal hypertension and massive splenomegaly?T Biss
Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
J Clin Pathol 57:999-1000. 2004..The proposed mechanism and the potential therapeutic options for this rare complication of myelofibrosis are discussed...
- Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcomeT T Biss
Department of Haematology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
Vox Sang 90:45-52. 2006..The aim of this study was to detect factors predictive of outcome and to incorporate them into a prognostically significant scoring system...
- Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literatureT T Biss
Newcastle Haemophilia Comprehensive Care Centre, Newcastle Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK
Haemophilia 12:280-4. 2006..We discuss the possible reasons for failure of immune tolerance induction and review the literature concerning the use of rituximab for this indication...